BRIGHT MINDS BIOSCIENCES INC (DRUG) Institutional Shareholders
BRIGHT MINDS BIOSCIENCES INC (DRUG) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $651.91M in DRUG holdings during the latest filing period.
Janus Henderson Group Plc is currently the largest disclosed institutional shareholder of DRUG tracked by InsiderSet, reporting ownership valued at approximately $93.52M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $78.32M, representing an estimated loss of -16.25% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed DRUG value among the investors covered in this analysis. Major shareholders include Janus Henderson Group Plc, Cormorant Asset Management, Lp, Blackrock, Inc., and several other long-term asset managers with concentrated positions in BRIGHT MINDS BIOSCIENCES INC (DRUG).
This page ranks the largest institutional DRUG shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
98
Total Reported Value
$651.91M
Largest Holder
Janus Henderson Group Plc
Largest Position
$93.52M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
117
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Janus Henderson Group Plc | 0.05% | 1,284,324 | $93,518,052 | $78,318,078 | -$15,199,974 | -16.25% | |
| Cormorant Asset Management, Lp | 3.24% | 900,000 | $63,180,000 | $54,882,000 | -$8,298,000 | -13.13% | |
| Blackrock, Inc. | 0.00% | 686,184 | $48,170,117 | $41,843,500 | -$6,326,617 | -13.13% | |
| Vivo Capital, Llc | 3.57% | 557,172 | $39,113,474 | $33,976,349 | -$5,137,125 | -13.13% | |
| Vestal Point Capital, Lp | 0.89% | 545,000 | $38,259,000 | $33,234,100 | -$5,024,900 | -13.13% | |
| Braidwell Lp | 1.26% | 483,822 | $33,964,304 | $29,503,466 | -$4,460,838 | -13.13% | |
| Driehaus Capital Management Llc | 0.18% | 433,377 | $30,423,065 | $26,427,329 | -$3,995,736 | -13.13% | |
| Balyasny Asset Management L.P. | 0.04% | 345,053 | $24,222,721 | $21,041,332 | -$3,181,389 | -13.13% | |
| Adage Capital Partners Gp, L.L.C. | 0.03% | 335,000 | $23,517,000 | $20,428,300 | -$3,088,700 | -13.13% | |
| Point72 Asset Management, L.P. | 0.04% | 327,416 | $22,984,603 | $19,965,828 | -$3,018,775 | -13.13% | |
| Deerfield Management Company, L.P. | 0.21% | 283,000 | $19,866,600 | $17,257,340 | -$2,609,260 | -13.13% | |
| Ra Capital Management, L.P. | 0.16% | 265,000 | $18,603,000 | $16,159,700 | -$2,443,300 | -13.13% | |
| Parkman Healthcare Partners Llc | 1.48% | 205,053 | $14,394,721 | $12,504,132 | -$1,890,589 | -13.13% | |
| Mpm Bioimpact Llc | 0.87% | 202,114 | $14,188,403 | $12,324,912 | -$1,863,491 | -13.13% | |
| Wellington Management Group Llp | 0.00% | 171,315 | $12,026,312 | $10,446,789 | -$1,579,523 | -13.13% | |
| Goldman Sachs Group Inc | 0.00% | 133,689 | $9,384,968 | $8,152,355 | -$1,232,613 | -13.13% | |
| Eventide Asset Management, Llc | 0.12% | 130,013 | $9,126,913 | $7,928,193 | -$1,198,720 | -13.13% | |
| State Street Corp | 0.00% | 122,178 | $8,576,896 | $7,450,414 | -$1,126,482 | -13.13% | |
| Seven Grand Managers, Llc | 0.34% | 120,000 | $8,424,000 | $7,317,600 | -$1,106,400 | -13.13% | |
| Great Point Partners Llc | 1.81% | 109,603 | $7,694,131 | $6,683,591 | -$1,010,540 | -13.13% | |
| Geode Capital Management, Llc | 0.00% | 104,146 | $7,311,049 | $6,350,823 | -$960,226 | -13.13% | |
| Orbimed Advisors Llc | 0.12% | 93,000 | $6,528,600 | $5,671,140 | -$857,460 | -13.13% | |
| Acuta Capital Partners, Llc | 4.54% | 92,745 | $6,510,699 | $5,655,590 | -$855,109 | -13.13% | |
| Ikarian Capital, Llc | 1.02% | 88,951 | $6,244,361 | $5,424,232 | -$820,129 | -13.13% | |
| Vanguard Portfolio Management Llc | 0.00% | 80,060 | $5,620,212 | $4,882,059 | -$738,153 | -13.13% | |
| Sio Capital Management, Llc | 0.89% | 73,952 | $5,191,430 | $4,509,593 | -$681,837 | -13.13% | |
| Trexquant Investment Lp | 0.03% | 70,615 | $4,957,173 | $4,306,103 | -$651,070 | -13.13% | |
| B Group, Inc. | 2.69% | 67,500 | $4,738,500 | $4,116,150 | -$622,350 | -13.13% | |
| Millennium Management Llc | 0.00% | 66,740 | $4,685,148 | $4,069,805 | -$615,343 | -13.13% | |
| Citadel Advisors Llc | 0.00% | 66,533 | $4,670,616 | $4,057,182 | -$613,434 | -13.13% | |
| Schonfeld Strategic Advisors Llc | 0.02% | 66,277 | $4,652,645 | $4,041,571 | -$611,074 | -13.13% | |
| Walleye Capital Llc | 0.02% | 66,106 | $4,640,641 | $4,031,144 | -$609,497 | -13.13% | |
| Woodline Partners Lp | 0.01% | 45,668 | $3,205,894 | $2,784,835 | -$421,059 | -13.13% | |
| Northern Trust Corp | 0.00% | 42,466 | $2,981,114 | $2,589,577 | -$391,537 | -13.13% | |
| Artia Global Partners Lp | 0.51% | 38,407 | $2,696,171 | $2,342,059 | -$354,112 | -13.13% | |
| Ameriprise Financial Inc | 0.00% | 37,902 | $2,660,720 | $2,311,264 | -$349,456 | -13.13% | |
| Los Angeles Capital Management Llc | 0.01% | 35,747 | $2,509,440 | $2,179,852 | -$329,588 | -13.13% | |
| Kvp Capital Advisors, Lp | 1.64% | 31,813 | $2,233,273 | $1,939,957 | -$293,316 | -13.13% | |
| Superstring Capital Management Lp | 1.35% | 30,456 | $2,138,011 | $1,857,207 | -$280,804 | -13.13% | |
| Adar1 Capital Management, Llc | 0.10% | 30,300 | $2,127,060 | $1,847,694 | -$279,366 | -13.13% | |
| Boothbay Fund Management, Llc | 0.04% | 27,870 | $1,956,474 | $1,699,513 | -$256,961 | -13.13% | |
| Bank Of America Corp | 0.00% | 26,966 | $1,893,013 | $1,644,387 | -$248,626 | -13.13% | |
| Advisorshares Investments Llc | 0.21% | 24,274 | $1,704,035 | $1,480,229 | -$223,806 | -13.13% | |
| Aquatic Capital Management Llc | 0.05% | 20,831 | $1,462,336 | $1,270,274 | -$192,062 | -13.13% | |
| Platinum Investment Management Ltd | 0.33% | 19,127 | $1,342,715 | $1,166,364 | -$176,351 | -13.13% | |
| Morgan Stanley | 0.00% | 18,599 | $1,305,698 | $1,134,167 | -$171,531 | -13.14% | |
| Charles Schwab Investment Management Inc | 0.00% | 18,032 | $1,265,846 | $1,099,591 | -$166,255 | -13.13% | |
| Nuveen, Llc | 0.00% | 16,889 | $1,185,608 | $1,029,891 | -$155,717 | -13.13% | |
| Ubs Group Ag | 0.00% | 15,536 | $1,090,627 | $947,385 | -$143,242 | -13.13% | |
| Bank Of New York Mellon Corp | 0.00% | 14,902 | $1,046,100 | $908,724 | -$137,376 | -13.13% |
Frequently asked questions about DRUG
Who owns the most DRUG stock?
The largest holders of DRUG are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BRIGHT MINDS BIOSCIENCES INC (DRUG).
Is DRUG widely held by superinvestors?
Many widely followed stocks like DRUG appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly DRUG is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.